Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dirk Maurer"'
Autor:
Doreen Dobritzsch, Judith Meijer, Rutger Meinsma, Dirk Maurer, Ardeshir A. Monavari, Anders Gummesson, Annika Reims, Jorge A. Cayuela, Natalia Kuklina, Jean-François Benoist, Laurence Perrin, Birgit Assmann, Georg F. Hoffmann, Jörgen Bierau, Angela M. Kaindl, André B.P. van Kuilenburg
Publikováno v:
Molecular genetics and metabolism, 136(3), 177-185. Academic Press Inc.
Molecular Genetics and Metabolism, 136(3), 177-185. Academic Press
Molecular Genetics and Metabolism, 136(3), 177-185. Academic Press Inc.
Molecular Genetics and Metabolism, 136(3), 177-185. Academic Press
Molecular Genetics and Metabolism, 136(3), 177-185. Academic Press Inc.
beta-Ureidopropionase is the third enzyme of the pyrimidine degradation pathway and catalyses the conversion of N-carbamyl-beta-alanine and N-carbamyl-beta-aminoisobutyric acid to beta-alanine and beta-aminoisobutyric acid, ammonia and CO2. To date,
Publikováno v:
Nucleic Acids Research
The iron-dependent regulator IdeR is the main transcriptional regulator controlling iron homeostasis genes in Actinobacteria, including species from the Corynebacterium, Mycobacterium and Streptomyces genera, as well as the erythromycin-producing bac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::804fc9b61d867793c23fd1d012155a67
https://doi.org/10.1101/2021.02.12.430932
https://doi.org/10.1101/2021.02.12.430932
Autor:
Maja Tarailo-Graovac, André B.P. van Kuilenburg, Colin Jd Ross, Doreen Dobritzsch, Judith Meijer, Rutger Meinsma, Clara D.M. van Karnebeek, Wyeth W. Wasserman, Britt I. Drögemöller, Lida Zoetekouw, Dirk Maurer, Jerry Vockley
Publikováno v:
Human mutation, 39(7), 947-953. Wiley-Liss Inc.
Dihydropyrimidine dehydrogenase (DPD) deficiency is associated with a variable clinical presentation. A family with three DPD-deficient patients presented with unusual clinical phenotypes including pregnancy-induced symptoms, transient visual impairm
Publikováno v:
The Biochemical journal. 475(14)
β-Ureidopropionase catalyzes the third step of the reductive pyrimidine catabolic pathway responsible for breakdown of uracil, thymine and pyrimidine-based antimetabolites such as 5-fluorouracil. Nitrilase-like β-ureidopropionases use a tetrad of c
Autor:
Dirk Maurer, Thao Chu, Thilak Reddy Enugala, Mikael Widersten, Emil Hamnevik, Robin Löfgren, Doreen Dobritzsch
Publikováno v:
Biochemistry. 57(7)
Laboratory evolution of alcohol dehydrogenase produced enzyme variants with improved turnover numbers with a vicinal 1,2-diol and its corresponding hydroxyketone. Crystal structure and transient kinetics analysis aids in rationalizing the new functio
Publikováno v:
Business Process Management Cases ISBN: 9783319583068
Business Process Management Cases
Business Process Management Cases
(a) Situation faced: The quality of the technical support of business processes plays an important role in the selection of corresponding software products. Against that background, software producers invest considerable capital and manpower in impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2df47689f6b8d36bd01a1b401def4e16
https://doi.org/10.1007/978-3-319-58307-5_16
https://doi.org/10.1007/978-3-319-58307-5_16
Autor:
Raoul C.M. Hennekam, Lia Knegt, Lieke H. van Huis-Tanja, André B.P. van Kuilenburg, Roel J.W. van Kampen, Doreen Dobritzsch, Vincent O. Dezentjé, Dirk Maurer, Lida Zoetekouw, Jens Michael Hertz, Judith Meijer, Rob L. H. Jansen, Rutger Meinsma, Maartje Los
Publikováno v:
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1863(3), 721-730. Elsevier
Biochimica et Biophysica Acta-Molecular Basis of Disease, 1863(3), 721-730. Elsevier Science
van Kuilenburg, A B P, Meijer, J, Maurer, D, Dobritzsch, D, Meinsma, R, Los, M, Knegt, L C, Zoetekouw, L, Jansen, R L H, Dezentjé, V, van Huis-Tanja, L H, van Kampen, R J W, Hertz, J M & Hennekam, R C M 2017, ' Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing ', BBA Molecular Basis of Disease, vol. 1863, no. 3, pp. 721-730 . https://doi.org/10.1016/j.bbadis.2016.12.010
Biochimica et Biophysica Acta-Molecular Basis of Disease, 1863(3), 721-730. Elsevier Science
van Kuilenburg, A B P, Meijer, J, Maurer, D, Dobritzsch, D, Meinsma, R, Los, M, Knegt, L C, Zoetekouw, L, Jansen, R L H, Dezentjé, V, van Huis-Tanja, L H, van Kampen, R J W, Hertz, J M & Hennekam, R C M 2017, ' Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing ', BBA Molecular Basis of Disease, vol. 1863, no. 3, pp. 721-730 . https://doi.org/10.1016/j.bbadis.2016.12.010
Dihydropyrimidine dehydrogenase (DPD) is the initial and rate-limiting enzyme in the catabolism of 5-fluorouracil (5FU). Genetic variations in DPD have emerged as predictive risk factors for severe fluoropyrimidine toxicity. Here, we report novel and